Discussion about this post

User's avatar
Tyler G's avatar

Hmm...I agree that poorly designed quality measures (antibiotics for pneumonia) are, on net, bad. I agree that all quality measures have negatives that need to be part of an cost/benefit evaluation. I agree that measures are probably net negative for the very best practitioners and systems. Incidentally, this is true for all metrics in all industries.

I don't think that it follows that all or most quality measures are bad on net, especially at the system/payer level. The A1c measure, for example, doesn't prescribe a treatment protocol (as the pneumonia one did.) Whether a patient's diabetes is uncontrolled due to lifestyle or medical factors, their health system (though maybe not an individual doctor) should try to help them improve it, and measuring success or failure is meaningful to incentivizing that.

I'm not totally clear on your argument yet though. One of the following?

1. All metrics are always or usually bad and healthcare quality metrics are no exception.

2. Quality measures in healthcare are always or usually bad for healthcare-specific reasons and should be eradicated.

3. Quality measures as they're currently implemented are bad, and they should be changed in xyz ways.

4. Quality measures are, on net, good, but not as uniformly beneficial as some VBC proponents think they are.

Expand full comment
1 more comment...

No posts